Katrina Thornber, Author at European Medical Journal - Page 16 of 54

New Hope for Resistant Type 2 Diabetes: Targeting Cortisol with Mifepristone

Cortisol-blocking treatment significantly improves blood sugar control and weight in people with hard-to-treat Type 2 diabetes.

Air Pollution Increases Risk of Atopic Dermatitis

Specifically, for every 10-μg/m³ increase in ambient air pollutants, there was a measurable increase in AD-related healthcare visits.

Europe Urged to Improve Newborn Biliary Atresia Screening

Biliary atresia is the most common surgical cause of cholestatic jaundice in infants and the leading reason for paediatric liver transplants

Saliva Testing Identifies Early Risk for Cancer and Chronic Diseases

Saliva-based DNA markers could predict cancer, heart disease, and more—offering a non-invasive future for early diagnosis.

MVA-BN Vaccine Offers Safe Mpox Protection in At-Risk Groups

A German multicentre study shows MVA-BN vaccination is safe and moderately effective in preventing mpox, especially in HIV-negative individuals.

Dupilumab Linked to Increased Psoriasis Risk in Atopic Dermatitis

Given dupilumab’s well-documented benefits in controlling moderate to severe AD, clinicians are advised to weigh this potential risk carefully against its therapeutic advantages.

AI Achieves High Accuracy in Automated Echocardiogram Interpretation

AI now matches experts in echocardiogram interpretation, promising faster, more accessible heart diagnostics for all patients.

EAN 2025: Blood Biomarker sNfL Predicts MS Relapses Up to a Year in Advance

Blood biomarker sNfL predicts MS relapses up to a year in advance, offering new hope for earlier intervention.

EAN 2025: ChatGPT-4o Rivals Neurology Experts in Diagnosing and Managing Polyneuropathy

AI tool GPT-4o boosts diagnosis accuracy for nerve disorders, helping non-specialists match expert recommendations in real cases.

EAN 2025: Nightmares Linked to Faster Ageing and Premature Mortality

Frequent nightmares accelerate ageing and triple risk of early death, highlighting a new target for preventive healthcare.